Fusion Pharmaceuticals Inc. — Net Income by Fiscal Year
5 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/05682607-6809-4a97-829e-885f2abd0976/serie/net-income
| Fiscal year | Net Income | Period | Evidence |
|---|---|---|---|
| FY 2023 | $-94.9M | 2023-01-01 – 2023-12-31 | evidence 0000950170-24-034172 |
| FY 2022 | $-87.6M | 2022-01-01 – 2022-12-31 | evidence 0000950170-23-008310 |
| FY 2021 | $-81.0M | 2021-01-01 – 2021-12-31 | evidence 0001564590-22-010720 |
| FY 2020 | $-78.3M | 2020-01-01 – 2020-12-31 | evidence 0001564590-21-015271 |
| FY 2019 | $-16.2M | 2019-01-01 – 2019-12-31 | evidence 0001564590-21-015271 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
Fusion Pharmaceuticals Inc. — all facts · Revenue · Operating Income